2016-004825-17: A Proof of concept study to investigate the effect of the antiviral medication "Telbivudine" in patients with inflammatory heart muscle disease caused by the Parvovirus Eine Machbarkeitsstudie über die Wirksamkeit des antiviralen Medikaments "Telbivudine" bei Patienten mit entzündlicher Herzmuskelerkrankung, die durch das Parvovirus verursacht ist |
|
|
| Ongoing | 2 | 25 | Europe | Sebivo, Tablet, Sebivo | Charité Universitätsmedizin Berlin, BMBF | Parvovirus B19-induced inflammatory cardiomyopathy Parvovirus B19-induzierte inflammatorische Kardiomyopathie, Parvovirus B19-induced inflammation of the heart muscle Parvovirus B19-ausgelöste Entzündung des Herzmuskels, Diseases [C] - Cardiovascular Diseases [C14] | | | | |
ChiCTR-TRC-10001100: The protective effect of Telbivudine combined Radiotherapy for patients with primary liver cancer with hepatitis B virus infection |
|
|
| Completed | 1/2 | 100 | | Radiotherapy only ;Radiotherapy combined Telbivudine | Zhongshan Hospital of Fudan University; Beijing Novartis Pharma Ltd., Beijing Novartis Pharma Ltd. | primary liver cancer with hepatitis B virus infection | | | | |
